相似文献
1
Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid treatment in gallstone subjects.
Gut. 1975 Jan;16(1):12-7. doi: 10.1136/gut.16.1.12.
2
Biliary lipid output during three meals and an overnight fast. I. Relationship to bile acid pool size and cholesterol saturation of bile in gallstone and control subjects.
Gut. 1975 Jan;16(1):1-11. doi: 10.1136/gut.16.1.1.
3
Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction.
Gastroenterology. 1991 Aug;101(2):490-6. doi: 10.1016/0016-5085(91)90029-k.
4
Effect of primary bile acid ingestion on bile acid metabolism and biliary lipid secretion in gallstone patients.
Gastroenterology. 1975 Dec;69(6):1301-14.
5
Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
J Clin Invest. 1973 Nov;52(11):2809-21. doi: 10.1172/JCI107477.
6
Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
Dig Dis Sci. 1982 Feb;27(2):161-8. doi: 10.1007/BF01311711.
7
The cholesterol saturation of bile and its reduction by chenodeoxycholic acid in massively obese patients.
Int J Obes. 1984;8(6):681-8.
8
Chenotherapy for gallstone dissolution. II. Induced changes in bile composition and gallstone response.
JAMA. 1978 Mar 20;239(12):1138-44. doi: 10.1001/jama.239.12.1138.
9
Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment.
Acta Chir Scand Suppl. 1985;528:1-38.
10
Biliary lipids, bile acids, and gallbladder function in the human female: effects of contraceptive steroids.
J Lab Clin Med. 1982 Jun;99(6):798-805.
引用本文的文献
1
Impact of trimethylamine N-oxide (TMAO) metaorganismal pathway on cardiovascular disease.
J Lab Precis Med. 2020 Apr;5. doi: 10.21037/jlpm.2020.01.01. Epub 2020 Apr 20.
2
Clinical pharmacokinetics of therapeutic bile acids.
Clin Pharmacokinet. 1996 May;30(5):333-58. doi: 10.2165/00003088-199630050-00002.
3
Lack of response to chenodeoxycholic acid in obese and non-obese patients. Role of cholesterol synthesis and possible response to ursodeoxycholic acid.
Gut. 1980 Dec;21(12):1082-6. doi: 10.1136/gut.21.12.1082.
4
In vitro studies on the interaction between bile salts and key enzymes of the liver.
Klin Wochenschr. 1982 Mar 1;60(5):237-42. doi: 10.1007/BF01728342.
5
Retrospective comparison of 'Cheno' and 'Urso' in the medical treatment of gallstones.
Gut. 1982 May;23(5):382-9. doi: 10.1136/gut.23.5.382.
6
Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Part II.
Dig Dis Sci. 1982 Sep;27(9):833-56. doi: 10.1007/BF01391378.
7
Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use.
Drugs. 1981 Feb;21(2):90-119. doi: 10.2165/00003495-198121020-00002.
8
Nucleation of cholesterol monohydrate crystals from hepatic and gall-bladder bile of patients with cholesterol gall stones.
Gut. 1983 Sep;24(9):836-44. doi: 10.1136/gut.24.9.836.
9
Effects of acute changes of bile acid pool composition on biliary lipid secretion.
J Clin Invest. 1984 Aug;74(2):614-24. doi: 10.1172/JCI111459.
10
The effects of 3,5,5-trimethylcyclohexanol on hepatic cholesterol synthesis, bile flow and biliary lipid secretion in the rat.
Br J Pharmacol. 1984 Jan;81(1):183-7. doi: 10.1111/j.1476-5381.1984.tb10759.x.
本文引用的文献
1
The physicochemical basis of cholesterol gallstone formation in man.
J Clin Invest. 1968 May;47(5):1043-52. doi: 10.1172/JCI105794.
2
The relation between formation of gallstones rich in cholesterol and the solubility of cholesterol in aqueos solutions of bile salts and lecithin.
Z Ernahrungswiss. 1971 Apr;10(3):239-52. doi: 10.1007/BF02020935.
3
Induced alterations in composition of bile of persons having cholelithiasis.
Gastroenterology. 1971 Oct;61(4):488-96.
4
Dissolution of cholesterol gallstones by chenodeoxycholic acid.
N Engl J Med. 1972 Jan 6;286(1):1-8. doi: 10.1056/NEJM197201062860101.
5
Diminished bile acid pool size in patients with gallstones.
Gastroenterology. 1970 Aug;59(2):165-73.
6
Cholesterol solubility in model bile systems: implications in cholelithiasis.
J Pharm Sci. 1974 Mar;63(3):327-32. doi: 10.1002/jps.2600630303.
7
Effect of bile acid feeding on cholesterol metabolism in gallstone patients.
Mayo Clin Proc. 1974 Apr;49(4):236-9.
8
Proceedings: Mechanism of action of chenodeoxycholic acid in gallstone dissolution.
Gut. 1973 Oct;14(10):826-7.
9
Letter: A simple calculation of the lithogenic index of bile: expressing biliary lipid composition on rectangular coordinates.
Gastroenterology. 1973 Oct;65(4):698-700.
10
Solubility of cholesterol in bile salt-lecithin model systems.
Am J Dig Dis. 1973 Aug;18(8):670-8. doi: 10.1007/BF01072038.
Zotero 插件